Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Tech Transfers column provides a monthly update on technology transfer deals, reporting licensing agreements between companies and universities or other research institutions within the In Vitro Diagnostics, Medical Device, and Pharmaceutical sectors. This month’s column covers deals announced August through September 2013.
Abcodia licenses proprietary ovarian cancer risk algorithm from MGH, Univ. of London
[Massachusetts General Hospital] and Queen Mary, University of London have granted biomarker validation company Abcodia Ltd. exclusive worldwide rights to ROCA (Risk of Ovarian Cancer Algorithm) for the...